Intratumoral heterogeneity of MYC drives medulloblastoma metastasis and angiogenesis

Abstract

Our study reveals the functional relevance of clonal diversity and highlights the therapeutic potential of targeting the secretome to interrupt interclonal communication and progression in high-risk MB.